Affinity Asset Advisors, LLC Ars Pharmaceuticals, Inc. Comm Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 400,000 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.